Histone deacetylase 2 regulates doxorubicin (Dox) sensitivity of colorectal cancer cells by targeting ABCB1 transcription. [electronic resource]
Producer: 20160726Description: 613-21 p. digitalISSN:- 1432-0843
- ATP Binding Cassette Transporter, Subfamily B -- genetics
- Antibiotics, Antineoplastic -- pharmacology
- Cell Line
- Cell Line, Tumor
- Colon -- cytology
- Colorectal Neoplasms -- drug therapy
- Down-Regulation -- genetics
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Epithelial Cells -- enzymology
- Gene Expression Regulation, Neoplastic
- Gene Knockdown Techniques
- Gene Silencing
- HCT116 Cells
- Histone Deacetylase 2 -- genetics
- Humans
- Multidrug Resistance-Associated Protein 2
- RNA, Small Interfering -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.